Impact of Drug Shortages on Cancer Care Delivery Within the National Cancer Institute Community Oncology Research Program
JCO Oncology Practice · 2026-05 · 22 (5) · 834-843
DOI: 10.1200/op-25-00057 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2026-05. Verfasst von Lauren V Ghazal und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester School of Nursing, Rochester, NY. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Delivery of Health Care, Medical Oncology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE Drug shortages represent a challenge in oncology care, with potential repercussions including suboptimal treatment options, treatment delays, and medication errors. However, there is scant evidence on how drug shortages interrupt cancer care delivery (CCD) nationally and specifically across National Cancer Institute (NCI) Community Oncology Research Program (NCORP) community oncology practices. METHODS Between December 2020 and July 2024, 96 NCORP community oncology practices were enrolled. NCORP practice study staff completed the Drug Shortage Baseline Survey and Pharmacy Baseline Survey. The primary outcome was proportion of practices seriously affected by drug shortages (ie, encountered CCD problems [change to less effective treatments, adoption of more toxic alternatives, treatment delays, or an increase in medication errors or near misses]) in the past 3 months. Secondary outcomes included CCD problems among practices (eg, ethical dilemmas) and strategies used by practices (eg, use of alternative drugs, stockpiling). Finally, we described differences between seriously affected and nonaffected practices. RESULTS Nearly 54% of NCORP practices were seriously affected by drug shortages in the past 3 months, with 23 drugs (including carboplatin [24.7%], leucovorin [22.6%], and cisplatin [19.4%]). Seriously affected practices were more likely to report lack of suitable alternatives (34.7% v 13.6%), substantial resources spent (70.8% v 50.0%), and change to alternative administration (73.5% v 52.3%) and were less likely to hire staff to address shortages (16.3% v 36.4%). Strategies to address shortages included using alternative drugs (91.5%), stockpiling (87.2%), and developing action plans (84.0%). Most (50.5%) practices reported experiencing an ethical dilemma related to a drug shortage. CONCLUSION Drug shortages influenced CCD among NCORP practices. This study underscores the need for robust strategies and policies to mitigate these effects and enhance the resilience of oncology practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Rochester School of Nursing, Rochester, NY.
- Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, URCC Research Base, Rochester, NY.
- Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY.
- University of Rochester School of Medicine & Dentistry, URCC Research Base, Rochester, NY.
- Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, Rochester, NY.
- Department of Economics, University of Rochester School of Medicine & Dentistry, Rochester, NY.
ORCID-Profile: Lauren V Ghazal, Kah Poh Loh, Eva Culakova, Judith O Hopkins, Charles Kamen, Erin R Fox, Elaine L Hill
Förderung
- NCI NIH HHS
Zitieren
APA
Ghazal, L. V., Mohile, S., Loh, K. P., Mustian, K., Sventek, G., Gada, U., Li, C. S., Culakova, E., Foust, M., Hopkins, J. O., Kehn, H., Kamen, C., Fox, E. R., & Hill, E. L. (2026). Impact of Drug Shortages on Cancer Care Delivery Within the National Cancer Institute Community Oncology Research Program. JCO Oncology Practice, 22(5), 834-843. https://doi.org/10.1200/op-25-00057
Vancouver
Ghazal LV, Mohile S, Loh KP, Mustian K, Sventek G, Gada U, et al. Impact of Drug Shortages on Cancer Care Delivery Within the National Cancer Institute Community Oncology Research Program. JCO Oncology Practice. 2026;22(5):834-843. doi:10.1200/op-25-00057
BibTeX
@article{Ghazal2026,
author = {Ghazal, Lauren V and Mohile, Supriya and Loh, Kah Poh and Mustian, Karen and Sventek, Grace and Gada, Umang and Li, Chin-Shang and Culakova, Eva and Foust, Melyssa and Hopkins, Judith O and Kehn, Heather and Kamen, Charles and Fox, Erin R and Hill, Elaine L},
title = {Impact of Drug Shortages on Cancer Care Delivery Within the National Cancer Institute Community Oncology Research Program},
journal = {JCO Oncology Practice},
year = {2026},
volume = {22},
number = {5},
pages = {834--843},
doi = {10.1200/op-25-00057}
}
EUVIMED